98 related articles for article (PubMed ID: 1314199)
1. Activation and regulation of the insulin receptor kinase.
Ballotti R; Baron V; Gautier N; Hainaut P; Scimeca JC; Dolais-Kitabgi J; Lammers R; Schlessinger J; Ullrich A; Van Obberghen E
Diabete Metab; 1992; 18(1 Pt 2):98-103. PubMed ID: 1314199
[TBL] [Abstract][Full Text] [Related]
2. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae.
Ballotti R; Lammers R; Scimeca JC; Dull T; Schlessinger J; Ullrich A; Van Obberghen E
EMBO J; 1989 Nov; 8(11):3303-9. PubMed ID: 2583100
[TBL] [Abstract][Full Text] [Related]
3. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor.
Riedel H; Dull TJ; Schlessinger J; Ullrich A
Nature; 1986 Nov 6-12; 324(6092):68-70. PubMed ID: 3024008
[TBL] [Abstract][Full Text] [Related]
4. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
Liu SM; Carpenter G
J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
[TBL] [Abstract][Full Text] [Related]
5. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
6. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced protein tyrosine kinase activity in living cells coexpressing intact EGF receptors and receptors with an extensive cytosolic deletion.
Dou Y; Hoffman P; Hoffman BL; Carlin C
J Cell Physiol; 1992 Nov; 153(2):402-7. PubMed ID: 1429858
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
9. [The insulin receptor: mechanism of activation and message transmission].
Ballotti R; Tartare S; Van Obberghen E
Pathol Biol (Paris); 1992 Oct; 40(8):754-62. PubMed ID: 1336594
[TBL] [Abstract][Full Text] [Related]
10. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
11. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
12. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
14. Activation and glucagon regulation of mitogen-activated protein kinases (MAPK) by insulin and epidermal growth factor in cultured rat and human hepatocytes.
Ulrich RG; Cramer CT; Adams LA; Kletzien RF
Cell Biochem Funct; 1998 Jun; 16(2):77-85. PubMed ID: 9636995
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction through the IL-4 and insulin receptor families.
Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
[TBL] [Abstract][Full Text] [Related]
16. Insulin-EGF receptor chimerae mediate tyrosine transphosphorylation and serine/threonine phosphorylation of kinase-deficient EGF receptors.
Tartare S; Ballotti R; Lammers R; Alengrin F; Dull T; Schlessinger J; Ullrich A; Van Obberghen E
J Biol Chem; 1991 May; 266(15):9900-6. PubMed ID: 1851758
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor transmembrane signaling: evidence for an intermolecular oligomerization mechanism of activation.
Mynarcik DC; Whittaker J
J Recept Signal Transduct Res; 1995; 15(7-8):887-904. PubMed ID: 8673722
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of phospholipase C phosphorylation by the epidermal growth factor receptor, the insulin receptor, and their cytoplasmic domains.
Nishibe S; Wahl MI; Wedegaertner PB; Kim JW; Rhee SG; Carpenter G
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):424-8. PubMed ID: 2153302
[TBL] [Abstract][Full Text] [Related]
19. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation.
Lammers R; Van Obberghen E; Ballotti R; Schlessinger J; Ullrich A
J Biol Chem; 1990 Oct; 265(28):16886-90. PubMed ID: 2170359
[TBL] [Abstract][Full Text] [Related]
20. Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity.
Tornqvist HE; Avruch J
J Biol Chem; 1988 Apr; 263(10):4593-601. PubMed ID: 2832399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
